Autolus Therapeutics plc (AUTL) › Capital ExpendituresAutolus Therapeutics plc (AUTL) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $1.85M2017: $2.88M2018: $9.12M2019: $18.34M2020: $14.68M2021: $8.86M2022: $10.84M2023: $10.99M2024: $22.07M2025: $19.04M$19.04M2016Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$19.04M-13.7%2024$22.07M+100.9%2023$10.99M+1.3%2022$10.84M+22.4%2021$8.86M-39.7%2020$14.68M-20.0%2019$18.34M+101.1%2018$9.12M+217.1%2017$2.88M+55.0%2016$1.85M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share